ArticleBMJ case reports2025
NXP-2-positive polymyositis associated with scrub typhus.
Article in BMJ case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polymyositis (PM), a rare autoimmune inflammatory myopathy, typically presents with symmetric proximal muscle weakness and elevated muscle enzymes. A muscle biopsy is confirmatory for the diagnosis. We report a case of a woman in her 30s with scrub typhus and anti-nuclear matrix protein 2 (NXP2) positive PM. The patient presented with fever, proximal muscle weakness, dysphagia and serologically confirmed scrub typhus a month prior. Laboratory investigations revealed a positive ELISA IgM for scrub typhus, elevated creatine kinase and elevated transaminases, leading to a provisional diagnosis of scrub myositis. However, further investigations, including electromyography, nerve conduction studies, muscle biopsy and the detection of myositis-specific anti-NXP-2 antibodies suggested PM. The patient was successfully treated with corticosteroids, cyclophosphamide and azathioprine, resulting in significant improvement of symptoms. This case highlights the importance of considering idiopathic inflammatory myopathy in patients with persistent muscle weakness and pain and underscores the need for a comprehensive diagnostic approach to ensure prompt and effective treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.